Header Logo

Connection

DANIEL D KARP to Genital Neoplasms, Female

Back to Details
This is a "connection" page, showing publications DANIEL D KARP has written about Genital Neoplasms, Female.
DANIEL D KARP
Connection Strength
0.134
Genital Neoplasms, Female
  1. Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies. Cancer. 2024 02 01; 130(3):400-409.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.